A detailed history of Quadrature Capital LTD transactions in En V Veno Medical Corp stock. As of the latest transaction made, Quadrature Capital LTD holds 39,229 shares of NVNO stock, worth $144,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,229
Holding current value
$144,362
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$2.49 - $3.65 $97,680 - $143,185
39,229 New
39,229 $119 Million
Q1 2024

May 14, 2024

BUY
$3.94 - $6.65 $74,355 - $125,498
18,872 New
18,872 $103 Million

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $34.8M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.